Skip to main content

We've saved some files called cookies on your device. These cookies are:

  • essential for the site to work
  • to help improve our website by collecting and reporting information on how you use it

We would also like to save some cookies to help tailor communications.

BETA
You're viewing an updated version of this service - your feedback will help us to improve it.

15 Voluntary ex ante Transparency (VEAT) Notice

Purchase of Hyperthermic Intraperitoneal Chemotherapy (HIPEC) Consumables

  • First published: 07 October 2024
  • Last modified: 07 October 2024

Contents

Summary

OCID:
ocds-kuma6s-144888
Published by:
NHS Wales Shared Services Partnership-Procurement Services (hosted by Velindre University NHS Trust)
Authority ID:
AA0221
Publication date:
07 October 2024
Deadline date:
-
Notice type:
15 Voluntary ex ante Transparency (VEAT) Notice
Has documents:
No
Has SPD:
No
Has Carbon Reduction Plan:
N/A

Abstract

Hyperthermic Intraperitoneal Chemotherapy (HIPEC) is a type of hyperthermia therapy used in combination with surgery in the treatment of advanced abdominal cancers. The Cardiff and Vale University Health Board completed an open tender procedure in 2022, to purchase the consumables, kit and maintenance required to complete HIPEC and has since received additional funding to continue the treatment process over the next 2 years. Without the repurchase of consumables, the service cannot continue, subsequently, the Health Board would need to send patients elsewhere for treatment. CPV: 33140000, 33140000.

Full notice text

Voluntary ex ante transparency notice

Directive 2014/24/EU

Section I: Contracting entity

I.1) Name and addresses

NHS Wales Shared Services Partnership-Procurement Services (hosted by Velindre University NHS Trust)

Woodland House, Maes YCoed Road

Cardiff

CF15 7QZ

UK

Contact person: Jessie Beavan

E-mail: jessie.beavan@wales.nhs.uk

NUTS: UK

Internet address(es)

Main address: http://nwssp.nhs.wales/ourservices/procurement-services/

Address of the buyer profile: https://www.sell2wales.gov.wales/search/Search_AuthProfile.aspx?ID=AA0221

I.4) Type of the contracting authority

Regional or local authority

I.5) Main activity

Health

Section II: Object

II.1) Scope of the procurement

II.1.1) Title

Purchase of Hyperthermic Intraperitoneal Chemotherapy (HIPEC) Consumables

II.1.2) Main CPV code

33140000

 

II.1.3) Type of contract

Supplies

II.1.4) Short description

Hyperthermic Intraperitoneal Chemotherapy (HIPEC) is a type of hyperthermia therapy used in combination with surgery in the treatment of advanced abdominal cancers. The Cardiff and Vale University Health Board completed an open tender procedure in 2022, to purchase the consumables, kit and maintenance required to complete HIPEC and has since received additional funding to continue the treatment process over the next 2 years. Without the repurchase of consumables, the service cannot continue, subsequently, the Health Board would need to send patients elsewhere for treatment.

II.1.6) Information about lots

This contract is divided into lots: No

II.1.7) Total value of the procurement

Value excluding VAT: 56 000.00  GBP

II.2) Description

II.2.2) Additional CPV code(s)

33140000

II.2.3) Place of performance

NUTS code:

UKL22

II.2.4) Description of the procurement

Hyperthermic Intraperitoneal Chemotherapy (HIPEC) is a type of hyperthermia therapy used in combination with surgery in the treatment of advanced abdominal cancers. The Cardiff and Vale University Health Board completed an open tender procedure in 2022, to purchase the consumables, kit and maintenance required to complete HIPEC and has since received additional funding to continue the treatment process over the next 2 years. Without the repurchase of consumables, the service cannot continue, subsequently, the Health Board would need to send patients elsewhere for treatment.

The original tender was awarded to Gamida LTD after the trial of multiple different supplier’s kit and consumables. The kit was purchased soon after from Gamida LTD. Now that the Health Board has received further funding for HIPEC treatment, there is a need to repurchase the necessary consumables from Gamida LTD to continue the service and treat patients, utilising the current equipment purchased as a result of the tender process.

For a continuity of service, the Health Board are direct awarding to Gamida LTD to continue providing the necessary treatment and service to patients.

II.2.11) Information about options

Options: No

II.2.13) Information about European Union funds

The procurement is related to a project and/or programme financed by European Union funds: No

Section IV: Procedure

IV.1) Description

IV.1.1) Type of procedure

Award of a contract without prior publication of a call for competition

Justification for selected award procedure:

The procurement falls outside the scope of application of the Directive

Explanation:

The original tender was awarded to Gamida LTD after the trial of multiple different supplier’s kit and consumables. The kit was purchased soon after from Gamida LTD. Now that the Health Board has received further funding for HIPEC treatment, there is a need to repurchase the necessary consumables from Gamida LTD to continue the service and treat patients, utilising the current equipment purchased as a result of the tender process.

For a continuity of service, the Health Board are direct awarding to Gamida LTD to continue providing the necessary treatment and service to patients.

IV.1.8) Information about Government Procurement Agreement (GPA)

The procurement is covered by the Government Procurement Agreement: Yes

Section V: Award of contract/concession

V.2 Award of contract/concession

V.2.1) Date of conclusion of the contract/concession

30/09/2024

V.2.2) Information about tenders

The contract has been awarded to a group of economic operators: No

V.2.3) Name and address of the contractor

GAMIDA SA

31 rue des alouettes

Eaubonne

95600

FR

NUTS: FR10

The contractor is an SME: No

V.2.4) Information on value of the concession and main financing terms (excluding VAT)

Total value of the concession/lot: 56 000.00  GBP

V.2.5) Information about subcontracting

Section VI: Complementary information

VI.3) Additional information

NOTE: To register your interest in this notice and obtain any additional information please visit the Sell2Wales Web Site at http://www.sell2wales.gov.wales/Search/Search_Switch.aspx?ID=144888.

(WA Ref:144888)

VI.4) Procedures for review

VI.4.1) Review body

High Court

Royal Courts of Justice, The Strand

London

WC2A 2LL

UK

Telephone: +44 2079477501

VI.5) Date of dispatch of this notice

07/10/2024

Coding

Commodity categories

ID Title Parent category
33140000 Medical consumables Medical equipments

Delivery locations

ID Description
1022 Cardiff and Vale of Glamorgan

Alert region restrictions

The buyer has restricted the alert for this notice to suppliers based in the following regions.

ID Description
There are no alert restrictions for this notice.

About the buyer

Main contact:
jessie.beavan@wales.nhs.uk
Admin contact:
N/a
Technical contact:
N/a
Other contact:
N/a

Further information

Date Details
No further information has been uploaded.

0800 222 9004

Lines are open 8:30am to 5pm Monday to Friday.

Rydym yn croesawu galwadau'n Gymraeg.

We welcome calls in Welsh.